menu
    • menu

    Company profile for INDICUS PHARMA

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Indicus Pharma is incorporated as a strategic alliance between USV Limited, India and Dr. Nitin Sheth (President & CEO: Indicus Pharma) with the goal of capitalizing on the opportunity in the US generic industry. This industry is growing due to various favorable factors such as increased awareness and acceptance of generics, as well as favorable legislation. Additionally, the large volume of branded products losing patent prot...
    Indicus Pharma is incorporated as a strategic alliance between USV Limited, India and Dr. Nitin Sheth (President & CEO: Indicus Pharma) with the goal of capitalizing on the opportunity in the US generic industry. This industry is growing due to various favorable factors such as increased awareness and acceptance of generics, as well as favorable legislation. Additionally, the large volume of branded products losing patent protection over the coming years and products which are already off-patent contribute to this growing opportunity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    INDICUS PHARMAUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Dr. Nitin Sheth, PH.DPresident & CEO
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://indicuspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Indicus Pharma’s Generic Propafenone Hydrochloride Receives Approval in the US
    Indicus Pharma’s Generic Propafenone Hydrochloride Receives Approval in the US

    05 Jul 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205956

    FDA
    05 Jul 2018
    Share Share
    Indicus Pharma's Generic Nateglinide Receives Approval In US
    Indicus Pharma's Generic Nateglinide Receives Approval In US

    21 Jun 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205544

    FDA
    21 Jun 2018
    Share Share
    Indicus's Generic Desipramine HCl approved in US as antidepressant drug
    Indicus's Generic Desipramine HCl approved in US as antidepressant drug

    05 May 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/indicuss-generic-desipramine-hcl-approved-in-us-as-antidepressant-drug-1462882780.pdf

    FDA
    05 May 2016
    Share Share
    Indicus’ Generic Aricept Approval Reveals Potential for U.S. Government Sales
    Indicus’ Generic Aricept Approval Reveals Potential for U.S. Government Sales

    15 Apr 2016

    // TWOFOUR INSIGHT

    http://twofourinsight.com/indicus-generic-aricept-approval-reveals-potential-us-government-sales/

    TWOFOUR INSIGHT
    15 Apr 2016
    Share Share
    Indicus Pharma's Generic Donepezil HCl approved in US to treat dementia
    Indicus Pharma's Generic Donepezil HCl approved in US to treat dementia

    12 Apr 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/indicus-pharmas-generic-donepezil-hcl-approved-in-us-to-treat-dementia-1460632945.pdf

    FDA
    12 Apr 2016
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search